Ceribell for Pediatrics

The First and Only FDA-cleared Seizure Detection Software Designed for All Pediatric Ages – From Preterm Newborns (25+ Weeks Postmenstrual Age) to Adults

Continuous Seizure Monitoring for Pediatric Patients in ICU and ED

Same Ceribell Headband, More Patients Monitored with Clarity®

Non-Convulsive Seizures Are Highly Prevalent and Often Undiagnosed in Critical Pediatric Patients

The Value of Point-of-Care EEG at the Bedside

Professional societies recommend timely EEG to detect and manage seizures given the prevalence of non-convulsive seizures

“If a patient is not showing clear signs of improvement [in] alertness within 10 minutes or still has any impairment of consciousness for more than 30 minutes after cessation of motor or other clinically-evident seizure activity, CCEEG should be considered to assess for ongoing seizure activity.”22

Common Patient Populations at Risk for NCSE

Prior Seizure with a Prolonged Post-Ictal Period

Altered Mental Status

Moderate to Severe TBI (GCS<12)

Cardiac Arrest or Other Hypoxic Event

Confident, Data-driven Bedside Decisions and Actions Made Possible With Clarity

Pediatric-specific Clarity Algorithm has Similar High Accuracy for Ruling Out and Detecting Continuous Seizures in Patients Ages 1-17 as With Adults

Initial Data in Pediatric Patients Shows Ceribell’s Positive Impact

ORDER TO DIAGNOSIS

IMPACT ON CARE

 

TIME & COST SAVINGS

 

decorative

References and Citations